FDAMA Off-Label Provisions Make FDA Sole Arbiter Of Scientific Data - WLF
Executive Summary
Provisions in the FDA Modernization Act of 1997 make the agency the sole arbiter of scientific merit, the Washington Legal Foundation stated in an April 29 brief filed in the WLF v. Henney case concerning off-label information dissemination.
You may also be interested in...
FDA Misgivings About Reprints Would Not Make Them "False" - WLF Lawyer
FDA will not be permitted to object to off-label reprints as "false and misleading" when the agency finds technical problems with an article, attorney Daniel Troy (Wiley, Rein & Fielding) asserted at an Aug. 18 Washington Legal Foundation forum on the impact of the recent WLF v. Henney off-label information dissemination ruling.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011